Progression free survival by the treatment with Cabozatinib in a case of BRAF mutated Radioiodine refractory recurrent metastatic Papillary Carcinoma Thyroid. (2026). Bangladesh Journal of Otorhinolaryngology, 31(2), 86-94. https://doi.org/10.3329/bjo.v31i2.89000